Production of the cryptic EefABC efflux pump in Enterobacter aerogenes chloramphenicol-resistant mutants

被引:16
作者
Masi, Muriel [1 ]
Pages, Jean-Marie [1 ]
Pradel, Elizabeth [1 ]
机构
[1] Univ Mediterranee, Fac Med, EA 2197, IFR48, F-13385 Marseille 05, France
关键词
drug efflux pumps; efflux inhibitors; multidrug resistance;
D O I
10.1093/jac/dkl139
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: AcrAB-ToIC is the major tripartite multidrug efflux pump in Enterobacter aerogenes while EefABC is a cryptic efflux system. This study was conducted to identify and characterize E. aerogenes mutants producing the EefABC efflux pump. Methods: Four spontaneous chloramphenicol-resistant (CMR) mutants were isolated. The expression level of the eefABC promoter and the production of the EefA and B proteins were analysed in the mutants. Antibiotic susceptibilities were compared for wild-type and mutant strains. Efflux activity was investigated using an efflux pump inhibitor. Results: The activation of the eefABC promoter was detected in four CMR mutants. These mutants showed increased resistance to erythromycin and ticarcillin, but not to fluoroquinolones, ketolides and detergents. Two additional efflux proteins were detected in the mutants. The CMR mutants bear no mutation in hns, which encodes a repressor of eefABC. No alteration of porin expression, a phenotype observed in marA or ramA multidrug-resistant mutants, was detected in the mutants. Conclusions: These observations suggest that eefABC activation can occur in vitro independently of the H-NS, MarA or RamA global regulators.
引用
收藏
页码:1223 / 1226
页数:4
相关论文
共 14 条
[1]   Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes [J].
Bornet, C ;
Chollet, R ;
Malléa, M ;
Chevalier, J ;
Davin-Regli, A ;
Pagès, JM ;
Bollet, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (04) :985-990
[2]   Most Enterobacter aerogenes strains in France belong to a prevalent clone [J].
Bosi, C ;
Davin-Regli, A ;
Bornet, C ;
Mallea, M ;
Pages, JM ;
Bollet, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (07) :2165-2169
[3]   National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998 [J].
De Gheldre, Y ;
Struelens, MJ ;
Glupczynski, Y ;
De Mol, P ;
Maes, N ;
Nonhoff, C ;
Chetoui, H ;
Sion, C ;
Ronveaux, O ;
Vaneechoutte, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) :889-896
[4]   TEM derivative-producing Enterobacter aerogenes strains:: Dissemination of a prevalent clone [J].
Dumarche, P ;
De Champs, C ;
Sirot, D ;
Chanal, C ;
Bonnet, R ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) :1128-1131
[5]   Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains [J].
Gayet, S ;
Chollet, R ;
Molle, G ;
Pagès, JM ;
Chevalier, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (05) :1555-1559
[6]   Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes [J].
Ghisalberti, D ;
Masi, M ;
Pagès, JM ;
Chevalier, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 328 (04) :1113-1118
[7]   Regulation of bacterial drug export systems [J].
Grkovic, S ;
Brown, MH ;
Skurray, RA .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2002, 66 (04) :671-+
[8]  
Köhler S, 1999, INFECT IMMUN, V67, P6695
[9]   IDENTIFICATION AND LOCATION OF L-GLYCERATE, AN UNUSUAL ACYL SUBSTITUENT IN GELLAN GUM [J].
KUO, MS ;
MORT, AJ ;
DELL, A .
CARBOHYDRATE RESEARCH, 1986, 156 :173-187
[10]   Efflux-mediated drug resistance in bacteria [J].
Li, XZ ;
Nikaido, H .
DRUGS, 2004, 64 (02) :159-204